Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction

NCT06980623 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT06980623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06980623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction
Lead sponsor
Brigham and Women's Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2025
Completion date
October 1, 2026
Enrollment
26,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, type 2 diabetes